Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPART'MUS: Prevention of Postpartum Relapses with Progestin and Estradiol in Multiple Sclerosis
2006-005460-30Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Nomegestrol + estradiol with Placebo (2 arms). Primary endpoint: Rate of relapses in first 12 weeks postpartum. Started Oct 2008; status: active.
02
Drugs
nomegestrolestradiol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-005460-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005460-30.